Categories: News

Altus Capital Partners-Backed MGC Diagnostics Corporation Acquires Lemon Medical, GmbH

SAINT PAUL, Minn.–(BUSINESS WIRE)–#cardiorespiratory–MGC Diagnostics Corporation (“MGC”), a global medical technology company dedicated to cardiorespiratory health solutions, and a portfolio company of Altus Capital Partners, Inc. (“Altus”), announced today the acquisition of Lemon Medical, GmbH. Lemon is a medical technology company, headquartered in Hammelburg, Germany. Financial terms of the transaction were not disclosed.

Lemon Medical, a German Limited Liability Company, founded in 2009, specializes in the design, development, production, and distribution of single-patient use disposables. These include viral and bacterial filters designed to protect patients, medical personnel, and diagnostic instruments against cross contamination during cardiorespiratory function testing. The usage of these protective products is experiencing significant growth because of the COVID pandemic and are now globally required patient safety components. In addition to the disposable products, Lemon develops, manufactures, and markets non-invasive diagnostic systems for detecting, classifying, and managing cardiorespiratory disease.

“MGC Diagnostics is excited to further strengthen its in-house manufacturing capabilities, product offering, and European presence through this acquisition of Lemon,” said Greg Greenberg, Co-Founder and Senior Partner of Altus Capital Partners. “We are thrilled about the opportunities this partnership will provide.”

“Following an exhaustive evaluation of the cardiorespiratory disposable filter market, MGC Diagnostics identified Lemon Medical, and its founder, Alfred Albert, as the ideal partner,” said Todd Austin, Chief Executive Officer of MGC. “This is another strategic acquisition for MGC Diagnostics, providing our own source of disposables as well as a significant footprint in the German market, one of the top cardiorespiratory scientific communities in the world.”

About MGC Diagnostics

Founded in 1977 and headquartered in Saint Paul, Minnesota, MGC Diagnostics Corporation, develops, manufactures, and markets non-invasive diagnostic systems for detecting, classifying, and managing cardiorespiratory disease. This singular focus guides its strategy and defines its commitment to customers, employees. and the cardiorespiratory industry. Its experience provides unmatched insight for solving today’s challenges and anticipating tomorrow’s opportunities. Please visit mgcdiagnostics.com for more information.

About Altus Capital Partners

Altus Capital Partners is a private equity firm that makes control investments in middle market manufacturing businesses that employ technology and automation. We believe that our exclusive focus on manufacturing provides us with a unique understanding of the opportunities and challenges faced by companies in the sector. We utilize a patient, thoughtful investment approach and partner with the management teams of our operating companies to achieve growth. Please visit altuscapitalpartners.com for more information.

About Lemon Medical, Inc.

Lemon Medical, a German Limited Liability Company, founded in 2009 by serial entrepreneur Alfred Albert, is headquartered in Hammelburg, Germany. Lemon Medical designs, develops, and distributes single patient use disposable bacterial and viral filters used in a variety of cardiorespiratory medical products. Please visit Lemon Medical for more information.

Contacts

Rosalia Scampoli

Marketcom PR
914-815-1465

rscampoli@marketcompr.com

Staff

Recent Posts

Celly Announces Increase of Term Loan

Toronto, Ontario--(Newsfile Corp. - April 8, 2024) - Celly Nutrition Corp. ("Celly Nu" or the…

7 hours ago

Biophytis Announces Its 2023 Financial Results and Provides an Update on Its Business Activities

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / April 8, 2024 / Biophytis SA (NASDAQ:BPTS),…

7 hours ago

FendX Reminds Shareholders of Webinar on April 11, 2024 to Showcase Recent Achievements and Provides Corporate Update

Oakville, Ontario--(Newsfile Corp. - April 8, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF)…

9 hours ago

ProAssurance Announces Dates for Release of First Quarter 2024 Results Release and Investor Teleconference

BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE:PRA) will report results for the quarter ended March 31, 2024…

10 hours ago

IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud

RESEARCH TRIANGLE PARK, N.C. & SAN FRANCISCO, CA--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of…

10 hours ago

Board-Certified and Highly Accomplished Active Duty Military Ophthalmologist Now Treating Patients at LasikPlus Lexington

LEXINGTON, KY / ACCESSWIRE / April 8, 2024 / Kentucky-based ophthalmologist and LASIK eye surgeon…

10 hours ago